Marcus Spann

Agonist-selective endocytosis of mu opioid receptor by neurons in vivo.

Catia Sternini, Marcus Spann, Duane E. Keith et al. · Proceedings of the National Academy of Sciences · 1996 · 328 citations · Full text

Synaptic Transmission, Immunology, Experimental Pharmacology +19

Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial

Humberto Nicolini, David Bakish, Héctor Dueñas et al. · Psychological Medicine · 2008 · 66 citations

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder

Christer Allgulander, D.J. Nutt, Michael J. Detke et al. · Journal of Psychopharmacology · 2008 · 41 citations

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy

Claus G. Roehrborn, Marcus Spann, Stephen L. Myers et al. · Prostate Cancer and Prostatic Diseases · 2014 · 37 citations

Prostatic Hypertrophy, Urology, Hormonal Receptor +6

Duloxetine 60 mg/day for the prevention of depressive recurrences:<i>post hoc</i>analyses from a recurrence prevention study

Katarina Kelin, Michael Berk, Marcus Spann et al. · International Journal of Clinical Practice · 2010 · 11 citations